PTH and hypercalcemia disease: Indeed, a post hoc analyses highlighted cinacalcet significantly reduced progression of SHPT to “severe unremitting” HPT (defined as two consecutive PTH values over 1,000 pg/mL, hypercalcemia, the use of cinacalcet with hypercalcemia, or patients requiring PTX) [29].